计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| T413234-25mg |
25mg |
现货 ![]() |
| |
| T413234-50mg |
50mg |
现货 ![]() |
| |
| T413234-100mg |
100mg |
现货 ![]() |
|
| 英文别名 | CANADINE DL-FORM [MI] | DTXCID802724 | Isoquinolino[2,1-b]isoquinoline, 5,6,7,8,13,13a-hexahydro-2,3-methylenedioxy-9,10-dimethoxy- | 10-METHOXY-5,8,13,13A-TETRAHYDRO-6H-[1,3]DIOXOLO[4,5-G]ISOQUINO[3,2-A]ISOQUINOLIN-9-YL METHYL ETHER | NCGC00016486-01 | N |
|---|---|
| 规格或纯度 | ≥99% |
| 英文名称 | Tetrahydroberberine |
| 生化机理 | 四氢小檗碱(Canadine)是一种异喹啉生物碱,对多巴胺 D2(拮抗剂,pKi = 6.08)和 5-HT1A (激动剂,pKi = 5.38)受体具有微摩尔亲和力,但对其他相关血清素受体的亲和力一般,甚至没有亲和力。 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 产品介绍 |
Information Tetrahydroberberine (Canadine) is an isoquinoline alkaloid with micromolar affinity fordopamine D2(antagonist, pKi = 6.08) and5-HT1A(agonist, pKi = 5.38) receptors but moderate to no affinity for other relevant serotonin receptors. Targets D2 receptor ; 5-HT1A 6.08(pKi); 5.38(pKi) In vivo Oral administration of THB not only resulted in significantly accelerated gastric emptying of normal rats in a bell-shaped relationship, with a maximal efficacy at a dose of 30 μg/kg, but also restored the delayed gastric emptying caused by apomorphine, which might be mediated by an antidopaminergic effect. |
| 纯度 | ≥99% |
| IC50 | D2 receptor, pKi: 6.08 |
|---|---|
| ALogP | 3.4 |
| Rotatable Bond | 2 |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| PubChem SID | 504753529 |
|---|---|
| 分子类型 | 小分子 |
| IIUPAC Name | 16,17-dimethoxy-5,7-dioxa-13-azapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-2,4(8),9,15(20),16,18-hexaene |
| INCHI | 1S/C20H21NO4/c1-22-17-4-3-12-7-16-14-9-19-18(24-11-25-19)8-13(14)5-6-21(16)10-15(12)20(17)23-2/h3-4,8-9,16H,5-7,10-11H2,1-2H3 |
| InChi Key | VZTUIEROBZXUFA-UHFFFAOYSA-N |
| Smiles | COC1=C(C2=C(CC3C4=CC5=C(C=C4CCN3C2)OCO5)C=C1)OC |
| Isomeric SMILES | COC1=C(C2=C(CC3C4=CC5=C(C=C4CCN3C2)OCO5)C=C1)OC |
| PubChem CID | 34458 |
| 分子量 | 339.39 |
| 溶解性 | Solubility (25°C) In vitro DMSO: 6 mg/mL (17.67 mM); |
|---|---|
| DMSO(mg / mL) Max Solubility | 6 |
| DMSO(mM) Max Solubility | 17.6787766286573 |
| 分子量 | 339.400 g/mol |
| XLogP3 | 3.100 |
| 氢键供体数Hydrogen Bond Donor Count | 0 |
| 氢键受体数Hydrogen Bond Acceptor Count | 5 |
| 可旋转键计数Rotatable Bond Count | 2 |
| 精确质量Exact Mass | 339.147 Da |
| 单同位素质量Monoisotopic Mass | 339.147 Da |
| 拓扑极表面积Topological Polar Surface Area | 40.200 Ų |
| 重原子数Heavy Atom Count | 25 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 488.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 1 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 象形图 | GHS07 |
|---|---|
| 信号词 | 警告 |
| 危险声明 |
H302: 吞食有害 |
| 预防措施声明 |
P264: 处理后要彻底洗手。 P270: 使用本产品时,请勿进食、饮水或吸烟。 P330: 漱口 P501: 将内容物/容器处理到。。。 P301+P317: 如果被吞咽:请寻求医疗帮助。 |
¥205.90